Skip Navigation



Nucleic Acids Research Advance Access published online on November 29, 2008

Nucleic Acids Research, doi:10.1093/nar/gkn830
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (1592K) Freely available
Right arrow Screen PDF (827K) Freely available
Right arrow Supplementary Data
Right arrowOA All Versions of this Article:
37/2/354    most recent
gkn830v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Zappulla, D. C.
Right arrow Articles by Wuttke, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zappulla, D. C.
Right arrow Articles by Wuttke, D. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2008 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Nucleic Acid Enzymes

Inhibition of yeast telomerase action by the telomeric ssDNA-binding protein, Cdc13p

David C. Zappulla1,*, Jennifer N. Roberts2, Karen J. Goodrich1, Thomas R. Cech1 and Deborah S. Wuttke2,*

1Howard Hughes Medical Institute and 2Department of Chemistry and Biochemistry, University of Colorado, Boulder, CO 80309, USA

*To whom correspondence should be addressed. Tel: +1 410 516 8749; Fax: +1 410 516 5213; Email: zappulla{at}jhu.edu

*Correspondence may also be addressed to Deborah S. Wuttke. Tel: +1 303 492 4576; Fax: +1 303 492 5894; Email: deborah.wuttke{at}colorado.edu

Received July 18, 2008. Revised September 16, 2008. Accepted October 14, 2008.

Appropriate control of the chromosome end-replicating enzyme telomerase is crucial for maintaining telomere length and genomic stability. The essential telomeric DNA-binding protein Cdc13p both positively and negatively regulates telomere length in budding yeast. Here we test the effect of purified Cdc13p on telomerase action in vitro. We show that the full-length protein and its DNA-binding domain (DBD) inhibit primer extension by telomerase. This inhibition occurs by competitive blocking of telomerase access to DNA. To further understand the requirements for productive telomerase 3'-end access when Cdc13p or the DBD is bound to a telomerase substrate, we constrained protein binding at various distances from the 3'-end on two sets of increasingly longer oligonucleotides. We find that Cdc13p inhibits the action of telomerase through three distinct biochemical modes, including inhibiting telomerase even when a significant tail is available, representing a novel ‘action at a distance’ inhibitory activity. Thus, while yeast Cdc13p exhibits the same general activity as human POT1, providing an off switch for telomerase when bound near the 3'-end, there are significant mechanistic differences in the ways telomere end-binding proteins inhibit telomerase action.


Present address: David C. Zappulla, Department of Biology, Johns Hopkins University, Baltimore, MD 21218-2685, USA

The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.